Abstracts

DEEPGEN™HIV

  1. “Characterization and validation of a deep sequencing-based HIV-1 genotypic and coreceptor tropism assay to simultaneously monitor susceptibility to maturation, protease, reverse transcriptase, and integrase inhibitors, and CCR5 antagonists” R.M. Gibson, A.M. Meyer, D. Winner, J. Archer, F. Feyertag, D.L. Robertson, E. Ruiz-Mateos, M. Leal, C. Schmotzer, & M.E. Quiñones-Mateu. Oral presentation. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies. Toronto, Canada (2013)(PDF)
  2. “Contribution of HIV minority variants to drug resistance in an integrase strand transfer inhibitor-based therapy” J. Weber, R.M. Gibson, A.M. Meyer, D. Winner, D.L. Robertson, M.D. Miller, & M.E. Quiñones-Mateu. Poster presentation. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies. Toronto, Canada (2013)(PDF)
  3. “Use of next-generation sequencing platforms to determine HIV-1 coreceptor tropism” M.E. Quiñones-Mateu, J. Archer, J. Weber, R. Gibson, E. Paxinos, E.J. Arts, D.L. Robertson, and L. Mimms. Late-breaker, Poster presentation. 52nd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy. San Francisco, CA (2012)(PDF)

VIRALARTS™HIV

  1. In vitro HIV-1 Cross-Resistance against RTI-based Microbicides” P. Selhorst, A.C. Vazquez, K. Terrazas-Aranda, J. Michiels,L. Heyndrickx,K. Ariën, M.E. Quiñones-Mateu, & G. Vanham. Poster presentation. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies. Dubrovnik, Croatia (2010)(PDF)
  2. “Antiviral Activity Profile and Characterization of Mutations Associated with Resistance to a Novel NRTI (OBP-601, Festinavir®) and their Impact on HIV-1 Replicative Fitness” A.C. Vazquez, J. Weber, M. Baba, D. Winner, J.D. Rose, A.M. Rhea, D. Wylie, Y. Urata, & M.E. Quiñones-Mateu. Poster presentation. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies. Dubrovnik, Croatia (2010)(PDF)
  3. “Resistance Mutations in Protease, Reverse Transcriptase, and Integrase Genes: Do They Have an Epistatic Effect on Drug Susceptibility and/or HIV-1 Replicative Fitness?” J. Weber, J.D. Rose, D. Wylie, A.C. Vazquez, A.M. Rhea, D. Winner, N. Margot, D. McColl, M. Miller, & M.E. Quiñones-Mateu. Poster presentation. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies. Dubrovnik, Croatia (2010)(PDF)
  4. “Characterization of Mutations Associated with Resistance to MPC-4326 (bevirimat) and their Impact on HIV-1 Replicative Fitness” J. Weber, J.D. Rose, A.C. Vazquez, D. Winner, A.M. Rhea, D. Wylie, K. Salzwedel, & M.E. Quiñones-Mateu. Poster presentation. International HIV & Hepatitis Virus Drug Resistance Workshop and Curative Strategies. Dubrovnik, Croatia (2010)(PDF)
  5. “Assessing HIV-1 cross-resistance in vitro against RTI-based microbicides currently under development” P. Selhorst, K. Terrazas-Aranda, J. Michiels, L. Heyndrickx, A. Vazquez, M. Quiñones-Mateu, K. Arien, & G. Vanham. Poster presentation. 2010 International Microbicides Conference (M2010). Pittsburgh, PA (2010)(PDF)
  6. “Characterization of Mutations Conferring Resistance to Integrase Inhibitors and their Impact on HIV-1 Replicative Fitness” A.M. Rhea, J. Weber, A.C. Vazquez, J.D. Rose, D. Winner, N. Margot, P.D. Olivo, D. McColl, M. Miller, & M.E. Quiñones-Mateu. Poster presentation. XVIII International HIV Drug Resistance Workshop. Fort Myers, FL (2009)(PDF)
  7. “Resistance Analysis to Maturation, Protease, Reverse Transcriptase, and Integrase Inhibitors Based on 3’Gag(p2/p7/p1/p6)/PR/RT/INT-Recombinant Viruses: A Useful Tool in the Multi-Target Era of Antiretroviral Drugs” J. Weber, J.D. Rose, A.M. Rhea, A.C. Vazquez, D. Winner, K. Henry, R. Gibson, P.D. Olivo, E. J. Arts, & M.E. Quiñones-Mateu. Poster presentation. XVIII International HIV Drug Resistance Workshop. Fort Myers, FL (2009)(PDF)
  8. “A novel system to produce fully infectious HIV-1 and its use in the determination of resistance to protease, reverse transcriptase, & integrase inhibitors in a single assay” M.E. Quiñones-Mateu, K.R. Henry, J. Weber, R. Gibson, A.C. Vazquez, Y. Gao, J. Weberova, D.M. Dudley, K.N. Nelson, I. Nankya, & E.J. Arts. Poster presentation. 24th Annual Clinical Virology Symposium & Annual Meeting Pan American Society for Clinical Virology. Daytona Beach, FL (2008)(PDF)
  9. “Quantification of resistance to protease, reverse transcriptase, and integrase inhibitors based on 3’Gag/PR/RT/INT-recombinant viruses: a useful tool in the upcoming era of integrase inhibitors” K. Henry, A.C. Vazquez, J. Weber, R. Gibson, J. Weberova, E.J. Arts, & M.E. Quiñones-Mateu. Poster presentation. 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA (2008)(PDF)
  10. “Drug susceptibility profile of OBP-601, a novel NRTI, using a comprehensive panel of NRTI and/or NNRTI resistant viruses” J. Weber, J. Weberova, A.C. Vazquez, T. Matsuda, Y. Urata, R.A. Shafer, E.J. Arts, & M.E. Quiñones-Mateu. Poster presentation. 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA (2008)(PDF)

VERITROP™

  1. “A novel phenotypicassay to determine HIV-1 co-receptor tropism”J. Weber, K. Henry, A.C. Vazquez, D. Winner, J. Archer, D. Robertson, E.J. Arts, and M.E. Quiñones-Mateu. Poster presentation. 28th Annual Clinical Virology Symposium and Annual Meeting of the Pan American Society for Clinical Virology. Daytona Beach, FL (2012)(PDF)
  2. “Accurate representation of in vivo HIV-1 quasispecies plays an important role in the quantification of viral tropism: a comparison of three different methods to generateenv-recombinant viruses” J. Weber, K. Henry, R. Gibson, J. Weberova, A.C. Vazquez, E.J. Arts, & M.E. Quiñones-Mateu. Poster presentation. 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA (2008)(PDF)
  3. “Lentiviral delivered VRX496 long antisense sequences exerts molecular pressure on HIV-1 in human subjects” V. Lukashov, M.E. Quiñones-Mateu, G. McGarrity, T. Rebello, & L. Humeau. Poster presentation. 15th Conference on Retroviruses and Opportunistic Infections. Boston, MA (2008)(PDF)

Make an Appointment

Schedule your appointment with a specialist at University Hospitals.
1-866-UH4-CARE (1-866-844-2273)

More Scheduling Options

Need to Refer a Patient?

Click here for Patient Referrals

Browse Services A-Z

Maps and Directions

Click here for directions